David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 166,982 shares at $70.42 ($11.8M) on 2024-02-27, disclosed to the SEC on 2024-02-28.
Scheduled sale ($11.8M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.60 | 26,516 | $1.9M | 15.8% |
| 2 | $70.60 | 26,516 | $1.9M | 15.8% |
| 3 | $71.31 | 2,037 | $145K | 1.2% |
| 4 | $71.31 | 2,037 | $145K | 1.2% |
| 5 | $69.45 | 4,448 | $309K | 2.6% |
| 6 | $69.45 | 4,448 |
| $309K |
| 2.6% |
| 7 | $70.42 | 21,152 | $1.5M | 12.6% |
| 8 | $70.42 | 21,152 | $1.5M | 12.6% |
| 9 | $71.32 | 25,944 | $1.9M | 15.7% |
| 10 | $71.32 | 25,944 | $1.9M | 15.7% |
| 11 | $71.97 | 3,394 | $244K | 2.1% |
| 12 | $71.97 | 3,394 | $244K | 2.1% |
| Total | $70.79 avg | 166,982 | $11.8M | 100% |
| Filing → |
| IMCR | SELL | 2025-12-01 | $6.0M | — | Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |